Bioinformation Therapy for Liver Cancer

Liver, Cancer of, Non-Resectable Clinical Trial

Official title:
Combination of Cancer Ablation and Life Information Rehabilitation Therapy for Unresectable Liver Cancer

Status Completed

Clinical Trial Summary

The aim of this study is the synergistic effect of cancer ablation and life information rehabilitation therapy on unresectable liver cancer.

Clinical Trial Description

By enrolling patients with unresectable liver cancer adapted to enrolled criteria, this study will document for the first time the synergistic effect of cancer ablation and life information rehabilitation therapy. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03239158
Study type	Interventional
Source	Fuda Cancer Hospital, Guangzhou
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	September 2, 2017
Completion date	September 2, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04090645` - TheraSphere & Treatment of Unresectable Primary or Unresectable Secondary Liver Cancer	N/A
Terminated	`NCT03563274` - QuiremSpheres Observational Study
Recruiting	`NCT05497453` - A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogene	Phase 1/Phase 2